{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:49:17Z","timestamp":1793742557290,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ygyno.2020.01.023","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T08:56:34Z","timestamp":1579510594000},"page":"195-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7397-8112","authenticated-orcid":false,"given":"Diede L.","family":"Loopik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"IntHout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e M.F.","family":"Ebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-0678","authenticated-orcid":false,"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2020.01.023_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2020.01.023_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"15","key":"10.1016\/j.ygyno.2020.01.023_bb0015","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.ejca.2013.04.024","article-title":"Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors","volume":"49","author":"Vaccarella","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.01.023_bb0020","author":"Integraal Kankercentrum Nederland"},{"issue":"9057","key":"10.1016\/j.ygyno.2020.01.023_bb0025","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(96)08295-5","article-title":"Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia","volume":"349","author":"Soutter","year":"1997","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ygyno.2020.01.023_bb0030","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ijc.21604","article-title":"Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia","volume":"118","author":"Soutter","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"7629","key":"10.1016\/j.ygyno.2020.01.023_bb0035","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","article-title":"Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study","volume":"335","author":"Strander","year":"2007","journal-title":"Bmj"},{"issue":"7526","key":"10.1016\/j.ygyno.2020.01.023_bb0040","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study","volume":"331","author":"Kalliala","year":"2005","journal-title":"Bmj"},{"key":"10.1016\/j.ygyno.2020.01.023_bb0045","article-title":"Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3\u2014a Danish nationwide cohort study","author":"Sand","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.01.023_bb0050","doi-asserted-by":"crossref","first-page":"e6855","DOI":"10.1136\/bmj.e6855","article-title":"Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study","volume":"345","author":"Rebolj","year":"2012","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.ygyno.2020.01.023_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0167-8140(89)90028-5","article-title":"Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study within a National Cancer Registry","volume":"16","author":"Pettersson","year":"1989","journal-title":"Radiother. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2020.01.023_bb0060","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jnci\/djp089","article-title":"Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study","volume":"101","author":"Melnikow","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.ygyno.2020.01.023_bb0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ejca.2011.05.002","article-title":"Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III","volume":"48","author":"Rapiti","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2020.01.023_bb0070","first-page":"S3\/78","article-title":"Chapter 9: clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ygyno.2020.01.023_bb0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/gyno.2000.5952","article-title":"Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?","volume":"79","author":"Nagai","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.01.023_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2011.11.023","article-title":"Follow-up after LLETZ: a study of 682 cases of CIN 2\u2013CIN 3 in a single institution","volume":"161","author":"Lubrano","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.01.023_bb0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","article-title":"Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study","volume":"12","author":"Kocken","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2020.01.023_bb0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jcp.2010.083626","article-title":"The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2\u20133","volume":"64","author":"Ovestad","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2020.01.023_bb0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000357907","article-title":"Human papillomavirus and immunosuppression","volume":"45","author":"Wieland","year":"2014","journal-title":"Curr. Probl. Dermatol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.01.023_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2008.11.022","article-title":"Routine follow-up intervals in patients with high-grade squamous intraepithelial lesions (HSIL) and free excision margins can safely be increased in the first two years after Large Loop Excision of the Transformation Zone (LLETZ)","volume":"113","author":"Eijsink","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2020.01.023_bb0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1600-0412.2012.01477.x","article-title":"Long-term compliance with follow-up after treatment for cervical intra-epithelial neoplasia","volume":"91","author":"Soutter","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2020.01.023_bb0110","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.ygyno.2020.01.023_bb0115","unstructured":"Statistics Netherlands (CBS). Mortality; Key Figures. The Hague\/Heerlen. . URL: http:\/\/statline.cbs.nl\/."},{"key":"10.1016\/j.ygyno.2020.01.023_bb0120","unstructured":"Statistics Netherlands (CBS). Population; Key Figures. The Hague\/Heerlen. . URL: http:\/\/statline.cbs.nl\/."},{"key":"10.1016\/j.ygyno.2020.01.023_bb0125","doi-asserted-by":"crossref","first-page":"f7361","DOI":"10.1136\/bmj.f7361","article-title":"Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality","volume":"348","author":"Strander","year":"2014","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.ygyno.2020.01.023_bb0130","first-page":"923","article-title":"Practice bulletin no. 168 summary: cervical cancer screening and prevention","volume":"128","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.01.023_bb0135","series-title":"Guidelines for the Management of Cervical Intraepithelial Neoplasia","author":"Swedish Society of Obstetricians and Gynecologists (SFOG)","year":"2010"},{"issue":"5 Suppl 1","key":"10.1016\/j.ygyno.2020.01.023_bb0140","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"10.1016\/j.ygyno.2020.01.023_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/LGT.0000000000000128","article-title":"Endocervical crypt involvement by CIN2\u20133 as a predictor of cytology recurrence after excisional cervical treatment","volume":"19","author":"Papoutsis","year":"2015","journal-title":"J Low Genit Tract Dis"},{"issue":"9","key":"10.1016\/j.ygyno.2020.01.023_bb0150","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/sj.bjc.6601764","article-title":"Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis","volume":"90","author":"Berrington de Gonzalez","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.01.023_bb0155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0959-8049(00)00376-2","article-title":"The role of human papillomavirus in cervical adenocarcinoma carcinogenesis","volume":"37","author":"Andersson","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2020.01.023_bb0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsague","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ygyno.2020.01.023_bb0165","first-page":"1025","article-title":"Follow up after LLETZ: could schedules be modified according to risk of recurrence?","volume":"108","author":"Flannelly","year":"2001","journal-title":"Bjog"},{"issue":"11","key":"10.1016\/j.ygyno.2020.01.023_bb0170","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1471-0528.2006.01063.x","article-title":"Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation","volume":"113","author":"Verguts","year":"2006","journal-title":"Bjog"},{"issue":"6","key":"10.1016\/j.ygyno.2020.01.023_bb0175","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1525-1438.2007.00945.x","article-title":"Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure","volume":"17","author":"Bae","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.01.023_bb0180","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.01.023_bb0185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2\u20133)?","volume":"130","author":"Kang","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.01.023_bb0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vaccination after treatment for CIN2","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.01.023_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-016-0293-9","article-title":"Perspectives for therapeutic HPV vaccine development","volume":"23","author":"Yang","year":"2016","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.ygyno.2020.01.023_bb0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ajog.2016.02.021","article-title":"Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment","volume":"215","author":"Hildesheim","year":"2016","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820300676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820300676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:48:46Z","timestamp":1758772126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820300676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0090825820300676"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.01.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}